{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:26:42Z","timestamp":1791592002378,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Swiss National Research Foundation","award":["31003A_146936"],"award-info":[{"award-number":["31003A_146936"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.drup.2015.10.001","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T20:42:10Z","timestamp":1446583330000},"page":"12-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"special_numbering":"C","title":["Defining the frontiers between antifungal resistance, tolerance and the concept of persistence"],"prefix":"10.1016","volume":"23","author":[{"given":"Eric","family":"Delarze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Sanglard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2015.10.001_bib0005","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nchembio.1496","article-title":"Amphotericin forms an extramembranous and fungicidal sterol sponge","volume":"10","author":"Anderson","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.drup.2015.10.001_bib0010","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MCC.0b013e32833e84d2","article-title":"Epidemiology of invasive candidiasis","volume":"16","author":"Arendrup","year":"2010","journal-title":"Curr. Opin. Crit. Care"},{"key":"10.1016\/j.drup.2015.10.001_bib0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.drup.2014.01.001","article-title":"Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp","volume":"16","author":"Arendrup","year":"2013","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.drup.2015.10.001_bib0020","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/QCO.0000000000000111","article-title":"Echinocandin resistance: an emerging clinical problem?","volume":"27","author":"Arendrup","year":"2014","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.drup.2015.10.001_bib0025","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1128\/AAC.44.8.2081-2085.2000","article-title":"Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis","volume":"44","author":"Arthington-Skaggs","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.10.001_bib0030","first-page":"S34","article-title":"Pharmacology of systemic antifungal agents","volume":"S1","author":"Ashley","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drup.2015.10.001_bib0035","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1128\/AAC.49.12.4989-4992.2005","article-title":"Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata","volume":"49","author":"Barchiesi","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.10.001_bib0040","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cmi.2015.07.005","article-title":"Differential association of fluconazole dose and dose\/MIC ratio with mortality in patients with Candida albicans and non-albicans bloodstream infection","volume":"21","author":"Brosh-Nissimov","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.drup.2015.10.001_bib0045","doi-asserted-by":"crossref","first-page":"165rv113","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.drup.2015.10.001_bib0050","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1128\/AAC.05414-11","article-title":"Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods","volume":"56","author":"Castanheira","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.10.001_bib0055","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1128\/EC.00151-07","article-title":"Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates","volume":"6","author":"Coste","year":"2007","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.drup.2015.10.001_bib0060","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1128\/EC.00069-09","article-title":"Functional analysis of cis- and trans-acting elements of the Candida albicans CDR2 promoter with a novel promoter reporter system","volume":"8","author":"Coste","year":"2009","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.drup.2015.10.001_bib0065","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.mib.2013.03.005","article-title":"The fungal Achilles\u2019 heel: targeting Hsp90 to cripple fungal pathogens","volume":"16","author":"Cowen","year":"2013","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.drup.2015.10.001_bib0070","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev.micro.56.012302.160907","article-title":"Evolution of drug resistance in Candida albicans","volume":"56","author":"Cowen","year":"2002","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.drup.2015.10.001_bib0075","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1126\/science.1118370","article-title":"Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi","volume":"309","author":"Cowen","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.drup.2015.10.001_bib0080","doi-asserted-by":"crossref","first-page":"a019752","DOI":"10.1101\/cshperspect.a019752","article-title":"Mechanisms of antifungal drug resistance","volume":"5","author":"Cowen","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.drup.2015.10.001_bib0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tim.2010.02.004","article-title":"Therapy for fungal diseases: opportunities and priorities","volume":"18","author":"Denning","year":"2010","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.drup.2015.10.001_bib0090","first-page":"121","article-title":"In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature","volume":"20","author":"Espinel-Ingroff","year":"2003","journal-title":"Rev. Iberoam. Micol."},{"key":"10.1016\/j.drup.2015.10.001_bib0095","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1128\/AAC.06017-11","article-title":"Potent synergistic effect of doxycycline with fluconazole against Candida albicans is mediated by interference with iron homeostasis","volume":"56","author":"Fiori","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.10.001_bib0100","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nature13469","article-title":"Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations","volume":"513","author":"Fridman","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.drup.2015.10.001_bib0105","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/1567-1364.12048","article-title":"Synergistic effect of doxycycline and fluconazole against Candida albicans biofilms and the impact of calcium channel blockers","volume":"13","author":"Gao","year":"2013","journal-title":"FEMS Yeast Res."},{"key":"10.1016\/j.drup.2015.10.001_bib0110","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1469-0691.2009.02913.x","article-title":"Antifungal pharmacokinetics and pharmacodynamics: bridging from the bench to bedside","volume":"15","author":"Hope","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.drup.2015.10.001_bib0115","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1093\/jac\/dku198","article-title":"In vivo imaging of disseminated murine Candida albicans infection reveals unexpected host sites of fungal persistence during antifungal therapy","volume":"69","author":"Jacobsen","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drup.2015.10.001_bib0120","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1128\/AAC.49.9.3616-3623.2005","article-title":"Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcome","volume":"49","author":"Kartsonis","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.10.001_bib0125","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1128\/AAC.48.5.1600-1613.2004","article-title":"Functional genomic analysis of fluconazole susceptibility in the pathogenic yeast Candida glabrata: roles of calcium signaling and mitochondria","volume":"48","author":"Kaur","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.10.001_bib0130","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1128\/AAC.05910-11","article-title":"Species-specific antifungal susceptibility patterns of scedosporium and pseudallescheria species","volume":"56","author":"Lackner","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.10.001_bib0135","doi-asserted-by":"crossref","first-page":"pe1001069","DOI":"10.1371\/journal.ppat.1001069","article-title":"PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90","volume":"6","author":"LaFayette","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drup.2015.10.001_bib0140","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1128\/AAC.00684-06","article-title":"Candida albicans biofilms produce antifungal-tolerant persister cells","volume":"50","author":"LaFleur","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.10.001_bib0145","doi-asserted-by":"crossref","first-page":"a019653","DOI":"10.1101\/cshperspect.a019653","article-title":"Antifungal Pharmacokinetics and Pharmacodynamics","volume":"5","author":"Lepak","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.drup.2015.10.001_bib0150","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrmicro1557","article-title":"Persister cells, dormancy and infectious disease","volume":"5","author":"Lewis","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.drup.2015.10.001_bib0155","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1128\/AAC.00543-15","article-title":"Delicate metabolic control and coordinated stress response critically determine antifungal tolerance of Candida albicans biofilm persisters","volume":"59","author":"Li","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.10.001_bib0160","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/jac\/dkv070","article-title":"The Rpd3\/Hda1 family of histone deacetylases regulates azole resistance in Candida albicans","volume":"70","author":"Li","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drup.2015.10.001_bib0165","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ijantimicag.2013.12.009","article-title":"Combination of fluconazole with non-antifungal agents: a promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery","volume":"43","author":"Liu","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.drup.2015.10.001_bib0170","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1128\/AAC.04239-14","article-title":"Trafficking through the late endosome significantly impacts Candida albicans tolerance of the azole antifungals","volume":"59","author":"Luna-Tapia","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.10.001_bib0175","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1128\/AAC.01645-09","article-title":"Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection","volume":"54","author":"MacCallum","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.10.001_bib0180","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1128\/AAC.44.11.2932-2938.2000","article-title":"Fluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans","volume":"44","author":"Marchetti","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.10.001_bib0185","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/AAC.44.9.2373-2381.2000","article-title":"Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans","volume":"44","author":"Marchetti","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.10.001_bib0190","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1128\/AAC.43.6.1383","article-title":"The trailing end point phenotype in antifungal susceptibility testing is pH dependent","volume":"43","author":"Marr","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.10.001_bib0195","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000","volume":"348","author":"Martin","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2015.10.001_bib0200","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00134-014-3404-7","article-title":"Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?","volume":"40","author":"Maubon","year":"2014","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.drup.2015.10.001_bib0205","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1567-1364.2010.00611.x","article-title":"Role of the Slt2 mitogen-activated protein kinase pathway in cell wall integrity and virulence in Candida glabrata","volume":"10","author":"Miyazaki","year":"2010","journal-title":"FEMS Yeast Res."},{"key":"10.1016\/j.drup.2015.10.001_bib0210","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1128\/JCM.02445-09","article-title":"Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species","volume":"48","author":"Pfaller","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.drup.2015.10.001_bib0215","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","article-title":"Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment","volume":"125","author":"Pfaller","year":"2012","journal-title":"Am. J. Med."},{"key":"10.1016\/j.drup.2015.10.001_bib0220","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.diagmicrobio.2014.03.004","article-title":"Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp","volume":"79","author":"Pfaller","year":"2014","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.drup.2015.10.001_bib0225","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1128\/JCM.00863-13","article-title":"In vitro activities of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and molds","volume":"51","author":"Pfaller","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.drup.2015.10.001_bib0230","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3109\/13693786.2011.583943","article-title":"Susceptibility of Candida species and various moulds to antimycotic drugs: use of epidemiological cutoff values according to EUCAST and CLSI in an 8-year survey","volume":"49","author":"Rambach","year":"2011","journal-title":"Med. Mycol."},{"key":"10.1016\/j.drup.2015.10.001_bib0235","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1128\/EC.2.6.1200-1210.2003","article-title":"The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signaling","volume":"2","author":"Reinoso-Mart\u00edn","year":"2003","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.drup.2015.10.001_bib0240","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/AAC.42.1.129","article-title":"Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis","volume":"42","author":"Rex","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl. 4","key":"10.1016\/j.drup.2015.10.001_bib0245","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1469-0691.2008.01978.x","article-title":"Changing epidemiology of systemic fungal infections","volume":"14","author":"Richardson","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.drup.2015.10.001_bib0250","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.celrep.2012.08.035","article-title":"Lysine deacetylases Hda1 and Rpd3 regulate Hsp90 function thereby governing fungal drug resistance","volume":"2","author":"Robbins","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2015.10.001_bib0255","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12281-011-0055-9","article-title":"Diagnosis of antifungal drug resistance mechanisms in fungal pathogens: transcriptional gene regulation","volume":"5","author":"Sanglard","year":"2011","journal-title":"Curr. Fungal Infect. Rep."},{"key":"10.1016\/j.drup.2015.10.001_bib0260","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1046\/j.1365-2958.2003.03495.x","article-title":"Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence","volume":"48","author":"Sanglard","year":"2003","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.drup.2015.10.001_bib0265","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1473-3099(02)00181-0","article-title":"Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences","volume":"2","author":"Sanglard","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.drup.2015.10.001_bib0270","doi-asserted-by":"crossref","first-page":"e1004211","DOI":"10.1371\/journal.ppat.1004211","article-title":"Systematic phenotyping of a large-scale Candida glabrata deletion collection reveals novel antifungal tolerance genes","volume":"10","author":"Schwarzm\u00fcller","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drup.2015.10.001_bib0275","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/jac\/dkp429","article-title":"In vitro activity of antifungal combinations against Candida albicans biofilms","volume":"65","author":"Tobudic","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drup.2015.10.001_bib0280","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/EC.00221-13","article-title":"UPC2 is universally essential for azole antifungal resistance in Candida albicans","volume":"13","author":"Vasicek","year":"2014","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.drup.2015.10.001_bib0285","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molcel.2015.05.011","article-title":"Obg and membrane depolarization are part of a microbial bet-hedging strategy that leads to antibiotic tolerance","volume":"59","author":"Verstraeten","year":"2015","journal-title":"Mol. Cell"}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764615000527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764615000527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T23:37:02Z","timestamp":1653435422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764615000527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":57,"alternative-id":["S1368764615000527"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2015.10.001","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining the frontiers between antifungal resistance, tolerance and the concept of persistence","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2015.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}